全球合成小分子 API 市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

全球合成小分子 API 市场需求预计将从 2022 年的 1358.8 亿美元达到 2030 年近 272.99 亿美元的市场规模，2023-2030 年研究期间复合年增长率为 8.06%。

合成小分子API是低分子量的活性药物成分。合成小分子 API 是用于生物过程和药物开发的有机成分。此外，任何药物成品都可以单独或组合使用API​​。它是製药行业必不可少的关键成分。该分子被证明在疾病的诊断、预防和治疗方面非常有效。合成小分子API的分子量为900道尔顿。

市场动态：

小分子 API 市场受到製药行业技术进步导致合成小分子 API 产量增加以及对仿製药需求不断增长的影响。多个治疗领域对慢性疾病有效治疗的需求推动了对合成小分子 API 的需求。人口老龄化的加剧、疾病和治疗意识的增强、研发活动的激增、医疗保健基础设施的改善以及医疗保健支出的增加是促进合成小分子原料药市场增长的几个因素。用于低成本药品生产的 API 等原材料的需求进一步加速了增长。外包趋势的增加和药物小规模生产的激增将进一步促进合成小分子 API 的市场增长。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球合成小分子原料药市场的各个细分市场进行了包容性评估。合成小分子原料药行业的增长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲合成小分子 API 市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。合成小分子 API 市场的主要参与者包括 Bristol-Myers Squibb Company、Cipla Inc.、Boehringer Ingelheim International GmbH、Merck & Co. Inc.、AbbVie Inc.、Aurobindo Pharma、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd. .、Albemarle Corporation、Viatris Inc.、Dr. Reddy's Laboratories Ltd.。本部分包含竞争格局的整体视图，其中包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他开发。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市场亮点
• 全球市场概况

第 3 章：合成小分子原料药 - 行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 行业动态
• 波特五力分析
• 市场吸引力分析
  • 製造商的市场吸引力分析
  • 市场吸引力分析：按应用分类
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原料厂商清单
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直效行销
  • 间接营销
  • 营销渠道发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球合成小分子 API 市场分析：按製造商分类

• 製造商概览
• 历史和预测数据
• 按製造商分析
• 内部
• 外包

第 7 章：全球合成小分子 API 市场分析：按应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 心脏病学
• 肿瘤学
• 中枢神经系统和神经病学
• 骨科
• 内分泌科
• 肺科
• 胃肠病学
• 肾脏病学
• 眼科
• 其他的

第 8 章：全球合成小分子 API 市场分析：按地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概述、历史和预测销售分析
  • 北美按细分市场销售分析
  • 北美按国家/地区销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家/地区销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家/地区销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：合成小分子原料药公司的竞争格局

• 合成小分子原料药市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 顶级公司市场份额分析
• 市场集中度
• Bristol-Myers Squibb Company
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Cipla Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Boehringer Ingelheim International GmbH
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Merck & Co. Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• AbbVie Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Aurobindo Pharma
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Sun Pharmaceutical Industries Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Teva Pharmaceutical Industries Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Albemarle Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Viatris Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Dr. Reddy's Laboratories Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

The global demand for Synthetic Small Molecule API Market is presumed to reach the market size of nearly USD 272.99 BN by 2030 from USD 135.88 BN in 2022 with a CAGR of 8.06% under the study period 2023 - 2030.

Synthetic small molecules API are active pharmaceutical ingredients with low molecular weight. The synthetic small molecule API is an organic component used in biological procedures and drug development. Furthermore, any finished pharmaceutical product can utilize API alone or in combination. It is an essential key ingredient in the pharmaceutical sector. The molecule is proven highly effective in the diagnosis, prevention & treatment of the disease. The molecular weight of synthetic small molecule API is 900 Daltons.

MARKET DYNAMICS:

The market for small molecule APIs is influenced by both the increased production of synthetic small molecule APIs as a result of technological advancement in the pharmaceutical industry and the rising need for generic drugs. The demand for synthetic small molecule API has been driven by the need for effective treatments for chronic diseases in several therapeutic fields. The growing ageing population & increase in disease & treatment awareness, the surge in R&D activities, improved healthcare infrastructure, and rising healthcare expenditure are several factors that are contributing to the market growth of synthetic small molecule API. Growth is further accelerated by the demand for raw materials like API for the low-cost manufacturing of drugs & pharmaceuticals. Increasing outsourcing trends and a surge in small-scale production of drugs will further augment the market growth of synthetic small molecule APIs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of synthetic small molecule api. The growth and trends of synthetic small molecule api industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the synthetic small molecule api market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Manufacturer

• In-House
• Outsourced

By Application

• Cardiology
• Oncology
• CNS And Neurology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
• Ophthalmology
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Synthetic Small Molecule API market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the synthetic small molecule api market include Bristol-Myers Squibb Company, Cipla Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., AbbVie Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Dr. Reddy's Laboratories Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . SYNTHETIC SMALL MOLECULE API - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Manufacturer
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL SYNTHETIC SMALL MOLECULE API MARKET ANALYSIS BY MANUFACTURER

• 6.1 Overview by Manufacturer
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Manufacturer
• 6.4 In-house Historic and Forecast Sales by Regions
• 6.5 Outsourced Historic and Forecast Sales by Regions

7 . GLOBAL SYNTHETIC SMALL MOLECULE API MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Application
• 7.4 Cardiology Historic and Forecast Sales by Regions
• 7.5 Oncology Historic and Forecast Sales by Regions
• 7.6 CNS And Neurology Historic and Forecast Sales by Regions
• 7.7 Orthopedic Historic and Forecast Sales by Regions
• 7.8 Endocrinology Historic and Forecast Sales by Regions
• 7.9 Pulmonology Historic and Forecast Sales by Regions
• 7.10. Gastroenterology Historic and Forecast Sales by Regions
• 7.11 Nephrology Historic and Forecast Sales by Regions
• 7.12 Ophthalmology Historic and Forecast Sales by Regions
• 7.13 Others Historic and Forecast Sales by Regions

8 . GLOBAL SYNTHETIC SMALL MOLECULE API MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SYNTHETIC SMALL MOLECULE API COMPANIES

• 9.1. Synthetic Small Molecule Api Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF SYNTHETIC SMALL MOLECULE API INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Bristol-Myers Squibb Company
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Cipla Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Boehringer Ingelheim International GmbH
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Merck & Co. Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. AbbVie Inc.
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Aurobindo Pharma
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Sun Pharmaceutical Industries Ltd.
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Teva Pharmaceutical Industries Ltd.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Albemarle Corporation
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Viatris Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Dr. Reddy's Laboratories Ltd.
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Manufacturer (USD MN)
• In-house Market Sales by Geography (USD MN)
• Outsourced Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Cardiology Market Sales by Geography (USD MN)
• Oncology Market Sales by Geography (USD MN)
• CNS And Neurology Market Sales by Geography (USD MN)
• Orthopedic Market Sales by Geography (USD MN)
• Endocrinology Market Sales by Geography (USD MN)
• Pulmonology Market Sales by Geography (USD MN)
• Gastroenterology Market Sales by Geography (USD MN)
• Nephrology Market Sales by Geography (USD MN)
• Ophthalmology Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Synthetic Small Molecule Api Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Synthetic Small Molecule Api Report
• Market Research Process
• Market Research Methodology
• Global Synthetic Small Molecule Api Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Manufacturer
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Manufacturer (USD MN)
• In-house Market Sales by Geography (USD MN)
• Outsourced Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Cardiology Market Sales by Geography (USD MN)
• Oncology Market Sales by Geography (USD MN)
• CNS And Neurology Market Sales by Geography (USD MN)
• Orthopedic Market Sales by Geography (USD MN)
• Endocrinology Market Sales by Geography (USD MN)
• Pulmonology Market Sales by Geography (USD MN)
• Gastroenterology Market Sales by Geography (USD MN)
• Nephrology Market Sales by Geography (USD MN)
• Ophthalmology Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.